4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-021051
VP and Chief Compliance Office acquired 3,000 shares (grant or award)
- VP and Chief Compliance Office gave up 2,066 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herman James L VP and Chief Compliance Office | 2019-03-22 | Grant or award | +3,000 | $5.98 | $17,940 | 45,949 | D |
| Herman James L VP and Chief Compliance Office | 2019-03-22 | Shares withheld for taxes | −2,066 | $5.62 | $11,611 | 43,883 | D |
Loading xslF345X03/doc4.xml…